| |
| |
|
| Insider
Information: |
Mueller Brian |
| Relationship: |
|
| City: |
Novato |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
82,159 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$6,395,452 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
82,159 |
|
|
| Total
Value |
$6,395,452 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biomarin Pharmaceutical Inc |
BMRN |
EVP, Chief Financial O... |
2024-05-30 |
72,159 |
|
0 |
Premium* |
|
|
Anthera Pharmaceuticals Inc |
ANTH |
|
2015-12-23 |
10,000 |
2015-12-23 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
139 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2022-08-05 |
4 |
OE |
$67.81 |
$237,335 |
D/D |
3,500 |
34,226 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2022-11-23 |
4 |
OE |
$67.81 |
$237,335 |
D/D |
3,500 |
32,347 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2022-12-02 |
4 |
OE |
$67.81 |
$400,079 |
D/D |
5,900 |
31,507 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Corporate Controller |
• – – |
2016-10-31 |
5 |
A |
$68.42 |
$4,242 |
D/D |
62 |
14,002 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2024-04-30 |
4 |
A |
$68.65 |
$20,594 |
D/D |
300 |
72,159 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Corporate Controller |
• – – |
2018-04-30 |
4 |
A |
$68.78 |
$19,740 |
D/D |
287 |
17,846 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Corporate Controller |
• – – |
2018-10-31 |
4 |
A |
$68.78 |
$1,513 |
D/D |
22 |
12,397 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Finance and CAO |
• – – |
2019-04-30 |
4 |
A |
$68.78 |
$20,566 |
D/D |
299 |
13,959 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Corporate Controller |
• – – |
2017-04-28 |
4 |
A |
$70.30 |
$18,982 |
D/D |
270 |
18,350 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
• – – |
2013-05-14 |
4 |
S |
$70.33 |
$348,045 |
D/D |
(4,947) |
6,660 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Acting CFO |
• – – |
2020-03-20 |
4 |
D |
$73.05 |
$30,243 |
D/D |
(414) |
24,781 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2024-05-30 |
4 |
AS |
$75.19 |
$375,950 |
D/D |
(5,000) |
72,159 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2021-04-01 |
4 |
AS |
$76.30 |
$434,300 |
D/D |
(5,692) |
31,016 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2021-03-16 |
4 |
D |
$77.21 |
$44,936 |
D/D |
(582) |
37,224 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2022-03-15 |
4 |
D |
$78.27 |
$146,208 |
D/D |
(1,868) |
38,881 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2021-03-15 |
4 |
D |
$78.39 |
$77,920 |
D/D |
(994) |
37,806 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2021-03-22 |
4 |
D |
$78.52 |
$40,516 |
D/D |
(516) |
36,708 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2021-05-07 |
4 |
AS |
$79.50 |
$533,366 |
D/D |
(6,709) |
31,357 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
• – – |
2016-03-16 |
4 |
D |
$80.34 |
$30,208 |
D/D |
(376) |
15,247 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2022-03-16 |
4 |
D |
$80.72 |
$46,979 |
D/D |
(582) |
38,299 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
• – – |
2016-05-06 |
4 |
D |
$80.80 |
$35,875 |
D/D |
(444) |
15,130 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Corporate Controller |
• – – |
2018-03-22 |
4 |
D |
$81.36 |
$33,683 |
D/D |
(414) |
17,559 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
• – – |
2016-05-13 |
4 |
D |
$82.71 |
$17,121 |
D/D |
(207) |
14,923 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2021-02-03 |
4 |
D |
$82.82 |
$88,700 |
D/D |
(1,071) |
28,673 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2021-06-29 |
4 |
D |
$83.46 |
$48,073 |
D/D |
(576) |
30,781 |
0 |
- |
|
139 Records found
|
|
Page 4 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
